A midlands man is thankful to be able to go into the new year after being diagnosed with a very aggressive form of cancer ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Annika, a 28-year-old from California, was diagnosed with a rare nasal cancer The cancer, sinonasal carcinoma SMARCB1, has ...